Skip to main content
. 2020 Apr 15;26(6):767–772. doi: 10.1016/j.cmi.2020.04.012

Table 3.

Laboratory results and imaging finding of the 663 COVID-19 patients

Total (n = 663) Disease severity
Improvement during follow-up
In-hospital death
Mild to moderate Severe Critical p value Yes No p value Survival Non-survival p value
Blood routine
 White blood cell
 Increased 80 (12.1) 18 (8.2) 29 (9.3) 33 (38.4) <0.001 18 (8.3) 62 (15.5) 0.011 70 (11.7) 10 (55.6) <0.001
 Neutrophil
 Increased 189 (28.5) 35 (15.8) 98 (31.4) 56 (65.1) <0.001 46 (21.1) 143 (35.7) <0.001 177 (29.5) 12 (66.7) 0.001
 Lymphocyte
 Decreased 338 (51.0) 77 (34.8) 186 (49.6) 75 (87.2) <0.001 78 (35.8) 260 (64.8) <0.001 322 (53.6) 16 (88.9) 0.006
 Haemoglobin
 Decreased 219 (33.0) 51 (23.1) 136 (43.6) 32 (37.2) <0.001 60 (27.5) 159 (39.7) 0.006 211 (35.1) 8 (44.4) 0.414
liver function
 Increased ALT 151 (22.8) 41 (18.6) 81 (26.1) 29 (33.7) 0.015 37 (17.0) 114 (28.6) 0.001 142 (23.7) 9 (50.0) 0.011
 Increased AST 171 (25.8) 40 (18.2) 91 (29.3) 40 (46.5) <0.001 40 (18.4) 131 (32.8) <0.001 160 (26.7) 11 (61.1) 0.001
Kidney function
 Damage 68 (10.3) 12 (5.5) 32 (10.3) 24 (27.9) <0.001 6 (2.8) 62 (15.5) <0.001 63 (10.5) 5 (27.8) 0.021
Infection-related Biomarkers
 Increased CRP 388 (58.5) 94 (50.5) 255 (79.2) 69 (92.0) <0.001 93 (49.5) 295 (82.6) <0.001 374 (70.4) 14 (100) 0.014
Other markers
 Decreased Albumin 444(67.0) 134 (61.8) 233 (74.9) 77 (89.5) <0.001 130 (60.2) 314 (78.7) <0.001 426 (71.4) 18 (100) 0.005
 Increased LDH 320(48.3) 67 (30.5) 179 (57.6) 74 (86.1) <0.001 65 (29.8) 255 (63.9) <0.001 306 (51.1) 14 (77.8) 0.046
CT
 Bilateral pneumonia 550 (83.0) 195 (86.7) 271 (95.4) 84 (98.8) <0.001 191 (58.7) 359 (96.8) <0.001 530 (92.3) 20 (100) 0.388

Data are n (%) unless specified otherwise.

ALT, alanine aminotransferase; AST, aspartate aminotransferase; Cr, creatinine; GFR, glomerular filtration rate; CRP, C-reactive protein; LDH, lactate dehydrogenase; CT, computed tomography.

P <0.05 was considered statistically significant.